Showing 91-100 of 114 results for "".
The Future of Fat Reduction
https://modernaesthetics.com/ma-issues-index/2024-july-aug/the-future-of-fat-reduction/35382/Weight-Loss Drugs Increase Need for Body Contouring and Other Aesthetic ProceduresUnleashing Femspan
https://modernaesthetics.com/ma-issues-index/2024-july-aug/unleashing-femspan/35384/Revolutionary approach to live longer youngerWhat’s Natural?
https://modernaesthetics.com/topics/skincare/whats-natural/35406/Defining and achieving this in-demand look- Industry Vet Didier Leclercq Joins Aerolase Leadership Teamhttps://modernaesthetics.com/news/industry-vet-didier-leclercq-joins-aerolase-leadership-team/2472958/Didier Leclercq is Aerolase’s new Vice President of Global Market Development. Prior to his role as Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, Mr. Leclercq ran Q-Med onc
- Ransomware Alert: Government Advisory Suggests Threat to Healthcare Systemhttps://modernaesthetics.com/news/ransomware-alert-government-advisory-suggests-threat-to-healthcare-system/2473012/A new advisory coauthored by the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI), and the Department of Health and Human Services (HHS) warns of the potential for ransomware attacks against hospitals and medical systems. “CI
- Glamour Ranks Best Face Moisturizershttps://modernaesthetics.com/news/glamour-ranks-best-face-moisturizers/2473574/Glamour released its “22 Best Face Moisturizers” list, naming SkinMedica’s HA5 Rejuvenating Hydrator the best overall. “I think my skin actually looks different—in a good way,” one tester said of the SkinMedica product. The monthslong process
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://modernaesthetics.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glutathio
- Study: Patients Prefer Top-to-Bottom Injection Techniquehttps://modernaesthetics.com/news/study-patients-prefer-top-to-bottom-injection-technique/2473627/Orienting the needle from top to bottom, taking into account migration to the upper lip, led to greater patient satisfaction in a study of lip rejuvenation techniques published in Cureus. Dr. Omer Buhsem conducted a randomized retrospective study of 216 female patients, using a top-to-b
- Will Platysma Prominence Be the Next Nod for BOTOX Cosmetic?https://modernaesthetics.com/news/will-platysma-prominence-be-the-next-nod-for-botox-cosmetic/2473497/Allergan Aesthetics’ BOTOX Cosmetic met all primary and secondary endpoints for the treatment of moderate to severe platysma prominence associated with platysma muscle activity, according to topline results from the second of three Phase 3 studies. The multicenter, randomized
- Cutera Introduces Secret DUOhttps://modernaesthetics.com/news/cutera-introduces-secret-duo/2473490/Cutera, Inc. is launching Secret DUO, a skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. Secret DUO is equipped